SSRI antidepressant product liability suits
Dr. Breggin has been involved in several landmark product liability cases against the manufacturers of SSRI antidepressant medications.
In the early 1990s Dr. Breggin was selected to be the scientific and medical expert for all of the more than 100 combined Prozac-related cases brought against the manufacturer, Eli Lilly and Company (makers of Prozac®). Dr. Breggin was asked to evaluate for the plaintiffs the scientific basis for the claim that Prozac® was causing violence and suicide, and also to evaluate the drug company’s potential negligence in the development and marketing of Prozac, including any attempts to hide the risk of Prozac-induced suicide and violence. He was also asked to evaluate individual cases for their merit.
Paxil® withdrawal suit resolved
A California lawsuit against Glaxo SmithKline (GSK) charged the drug company with failing to warn the public about the dangers of Paxil® withdrawal.
Suit brought on behalf of the citizens of California focusing on alleged fraud on the part of SmithKline Beecham in regard to the difficulties involved in withdrawing from their antidepressant Paxil®. The case provides a model for fraud and class action suits in other states and on a national level.
Articles by Dr. Breggin relating to some of the SSRI malpractice and product liability cases above: